Form 4 for AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL
Accepted 2026-05-22 16:44:39 ET · period of report 2026-05-20 · accession 0001213900-26-060632 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-22 16:44 | 2026-05-21 | AAPG | Zhai Yifan | Chief Medical Off | M - OptEx | $0.00 | +92.7K | 405.3K | +30% | $0 |
| DI | 2026-05-22 16:44 | 2026-05-21 | AAPG | Zhai Yifan | Chief Medical Off | M - OptEx | $0.00 | +95.6K | 1.19M | +9% | $0 |
| DM | 2026-05-22 16:44 | 2026-05-20 | AAPG | Zhai Yifan | Chief Medical Off | A - Grant | $0.00 | +729.5K | 92.7K | New | $0 |
| D | 2026-05-22 16:44 | 2026-05-21 | AAPG | Zhai Yifan | Chief Medical Off | M - OptEx | $0.00 | -92.7K | 0 | -100% | $0 |
| DMI | 2026-05-22 16:44 | 2026-05-20 | AAPG | Zhai Yifan | Chief Medical Off | A - Grant | $0.00 | +692.0K | 298.2K | New | $0 |
| DI | 2026-05-22 16:44 | 2026-05-21 | AAPG | Zhai Yifan | Chief Medical Off | M - OptEx | $0.00 | -95.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-05-21 | M | A | 92,746 | $0.00 | 405,280 | D | — | — | |
| 2 | Common | Ordinary Shares | 2026-05-21 | M | A | 95,575 | $0.00 | 1,193,569 | I See Footnote (2) | — | — | (F2) Shares held by Reporting Person's spouse. The Reporting Person disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. |
| 3 | Derivative | Restricted stock units | 2026-05-20 | A | A | 103,365 | $0.00 | 103,365 | D | $0.00 · — to — | 103,365 Ordinary Shares | (F4) Each restricted stock unit (the "RSUs") represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and have no expiration date. (F4) Each restricted stock unit (the "RSUs") represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and have no expiration date. (F4) Each restricted stock unit (the "RSUs") represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and have no expiration date. |
| 4 | Derivative | Restricted stock units | 2026-05-20 | A | A | 214,999 | $0.00 | 214,999 | D | $0.00 · — to — | 214,999 Ordinary Shares | (F5) The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date. (F5) The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date. (F5) The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date. |
| 5 | Derivative | Options | 2026-05-20 | A | A | 214,988 | $0.00 | 214,988 | D | $6.58 · — to — | 214,988 Ordinary Shares | (F6) The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant. (F6) The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant. (F6) The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant. |
| 6 | Derivative | Options | 2026-05-20 | A | A | 103,364 | $0.00 | 103,364 | D | $8.12 · — to — | 103,364 Ordinary Shares | (F7) The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and expire ten years from the date of grant. (F7) The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and expire ten years from the date of grant. (F7) The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and expire ten years from the date of grant. |
| 7 | Derivative | Restricted stock units | 2026-05-20 | A | A | 92,746 | $0.00 | 92,746 | D | $0.00 · 2026-05-21 to — | 92,746 Ordinary Shares | (F8) The RSUs vested on 05/21/2026 and had no expiration date. (F8) The RSUs vested on 05/21/2026 and had no expiration date. |
| 8 | Derivative | Restricted stock units | 2026-05-21 | M | D | 92,746 | $0.00 | 0 | D | $0.00 · — to — | 92,746 Ordinary Shares | (F9) Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026. (F9) Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026. (F9) Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026. |
| 9 | Derivative | Restricted stock units | 2026-05-20 | A | A | 95,575 | $0.00 | 95,575 | I By Spouse | $0.00 · 2026-05-21 to — | 95,575 Ordinary Shares | (F8) The RSUs vested on 05/21/2026 and had no expiration date. (F8) The RSUs vested on 05/21/2026 and had no expiration date. |
| 10 | Derivative | Restricted stock units | 2026-05-21 | M | D | 95,575 | $0.00 | 0 | I By Spouse | $0.00 · — to — | 95,575 Ordinary Shares | (F10) Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person's spouse on 05/20/2026. (F10) Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person's spouse on 05/20/2026. (F10) Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person's spouse on 05/20/2026. |
| 11 | Derivative | Restricted stock units | 2026-05-20 | A | A | 298,195 | $0.00 | 298,195 | I By Spouse | $0.00 · — to — | 298,195 Ordinary Shares | (F5) The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date. (F5) The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date. (F5) The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date. |
| 12 | Derivative | Options | 2026-05-20 | A | A | 298,194 | $0.00 | 298,194 | I By Spouse | $6.58 · — to — | 298,194 Ordinary Shares | (F6) The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant. (F6) The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant. (F6) The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant. |